Projects per year
Personal profile
External positions
Assistant Professor of Clinical Medicine, Weill Cornell Medical College
Sep 1 2021 → …
Research Area Keywords
- Cancer
Fingerprint
Dive into the research topics where Shilpan Shah is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Phase III_Parsaclisib and Ruxolitinib_Myelofibrosis_INCB 50465-313 A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Combination of PI3K Inhibitor Parsaclisib and Ruxolitinib in Participants With Myelofibrosis
Shah, S., Ganguly, S., Petkova, J., Pingali, S. R. & Rice, L.
8/23/21 → …
Project: Clinical Trial
-
Phase 3_NavitoclaxRuxolitinib_Myelofibrosis_Abbvie M20-178 Transform-2
Shah, S., Ganguly, S., Pingali, S. R. & Rice, L.
6/7/21 → …
Project: Clinical Trial
-
A Phase 2 Open-label Study of Brentuximab Vedotin in Front-line Therapy of Hodgkin Lymphoma (HL) an dCD30-expressing Peripheral T-cell Lymphoma (PTCL) in Older Patients or Patients With Significant Comorbidities Ineligible for Standard Chemotherapy
Pingali, S. R., Ganguly, S., Petkova, J., Rice, L. & Shah, S.
Project: Clinical Trial
-
A Phase 3 Open-Label, Randomized Study of Fixed Duration Pirtobrutinib (LOXO-305) Plus Venetoclax and Rituximab Versus Venetoclax and Rituximab in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN CLL-322)
Shah, S., Ganguly, S., Petkova, J., Pingali, S. R. & Rice, L.
Project: Clinical Trial
-
Use of ifosfamide, carboplatin and etoposide in combination with brentuximab vedotin or romidepsin based on CD30 positivity in relapsed/refractory peripheral T-cell lymphoma
Gentille, C., Sarfraz, H., Joshi, J., Randhawa, J., Shah, S. & Pingali, S. R., 2022, (Accepted/In press) In: Cancer Reports.Research output: Contribution to journal › Article › peer-review
Open Access -
Multiple myeloma with concurrent immune thrombocytopenic purpura
Sarfraz, H., Anand, K., Liu, S. & Shah, S., 2020, In: ecancermedicalscience. 14, 1012.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
The development of T-cell malignancies in patients with pre-existing myeloproliferative neoplasms: A report of three cases
Burns, E. A., Anand, K., Chung, B., Shah, S., Randhawa, J. K. & Pingali, S. R., 2020, In: ecancermedicalscience. 14, 1011.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Use of rituximab in lymphomatoid granulomatosis with isolated central nervous system involvement
Mooneyham, J., Gentille, C., Barbieri, A. & Shah, S., Sep 7 2020, In: BMJ Case Reports. 13, 9, 235412.Research output: Contribution to journal › Article › peer-review
-
Discovery of imatinib-responsive FIP1L1-PDGFRA mutation during refractory acute myeloid leukemia transformation of chronic myelomonocytic leukemia
Shah, S., Loghavi, S., Garcia-Manero, G. & Khoury, J. D., Mar 27 2014, In: Journal of Hematology and Oncology. 7, 1, 26.Research output: Contribution to journal › Article › peer-review
Open Access14 Scopus citations